Added value of pretreatment (18)F-FDG PET/CT for staging of advanced gastric cancer: Comparison with contrast-enhanced MDCT. 2016/05
2.
症例報告
11C-Choline positive but 18F-FDG negative pancreatic metastasis from renal cell carcinoma on PET 2017/02
3.
原著
Choline PET/CT Imaging for Management of Prostate Cancer 2017/03
4.
原著
11C-Choline positive but 18F-FDG negative pancreatic metastasis from renal cell carcinoma on PET 2017/05
5.
原著
Pravastatin reduces radiation-induced damage in normal tissues. 2017/05
6.
症例報告
Diagnostic performance of (11)C-choline PET/CT and bone scintigraphy in the detection of bone metastases in patients with prostate cancer. 2017/08
7.
症例報告
Tiny Obturator Node Metastasis from Prostate Cancer Not Shown by FDG-PET/CT, CT, or MRI Detected by11C-Choline PET/CT. 2018/01
8.
その他
Tumor response to neoadjuvant chemotherapy in patients with esophageal cancer assessed with CT and FDG-PET/CT - RECIST 1.1 vs. PERCIST 1.0. 2018/04
9.
原著
Assessment of tumor response to neoadjuvant chemotherapy in patients with breast cancer using MRI and FDG-PET/CT-RECIST 1.1 vs. PERCIST 1.0 2018/05
10.
その他
Assessment of tumor response to neoadjuvant chemotherapy in patients with breast cancer using MRI and FDG-PET/CT-RECIST 1.1 vs. PERCIST 1.0. 2018/05
11.
研究報告
心膜横隔静脈からのB-RTO 2018/05
12.
その他
Diagnostic Performance of 11C-choline PET/CT and FDG PET/CT in Prostate Cancer. 2018/06
13.
原著
Comparison of 11C-choline Positron Emission Tomography/Computed Tomography (PET/CT) and Conventional Imaging for Detection of Recurrent Prostate Cancer. 2018/07
14.
原著
The Potential Use of 11C-Choline Positron Emission Tomography/Computed Tomography to Monitor the Treatment Effects of Radium-223 in a Patient with Prostate Cancer. 2018/07
Diagnostic performance of 11C-choline PET/CT and FDG PET/CT for staging and restaging of renal cell cancer. 2018/08
17.
原著
Imaging of renal cell carcinoma in patients with acquired cystic disease of the kidney: comparison 11C-choline and FDG PET/CT with dynamic contrast-enhanced CT 2018/10
18.
原著
Clinical T staging is superior to fluorodeoxyglucose positron emission tomography for predicting local outcomes after intra-arterial chemoradiotherapy for maxillary sinus squamous cell carcinoma. 2018/11
19.
原著
Usefulness of quantitative bone single photon emission computed tomography/computed tomography for evaluating response to neoadjuvant chemotherapy in a patient with periosteal osteosarcoma. 2018/11
20.
原著
Diagnostic performance of 11C-choline PET/CT and FDG PET/CT for staging and restaging of renal cell cancer. 2018/12
21.
原著
Early evaluation of tumor response to90 2019/07
22.
原著
Evaluation of Treatment Response in Prostate Cancer and Renal Cell Carcinoma Patients Using 11C-choline PET/CT Findings. 2019/08
23.
原著
Diffusion-weighted MRI, 11 C-choline PET/CT, and 18 F-FDG PET/CT for Predicting the Gleason Score in Prostate Cancer 2020/03
24.
症例報告
Accurate Monitoring of the Response of Bone Metastases to Treatment in Patients with Prostate Cancer Using Choline PET/CT. 2021/01
25.
症例報告
CT Findings of Primary Renal Angiosarcoma. 2021/01
26.
症例報告
Metastasis-Directed Radiotherapy for Oligoprogressive Castration-Resistant Prostate Cancer Recurrence Revealed by Choline PET/CT. 2021/01
27.
症例報告
Pelvic MRI, FDG-PET/CT, and Somatostatin Receptor Scintigraphy Findings of Treatment-Related Neuroendocrine-Differentiated Prostate Cancer. 2021/01
28.
原著
Assessment of the viability and treatment response of bone metastases in patients with metastatic castration-resistant prostate cancer using choline PET/CT. 2021/06
29.
症例報告
MRI Finding of Prostatic Ductal Adenocarcinoma. 2021/09
30.
原著
CT and MRI Findings of Inflammatory Myofibroblastic Tumor in the Bladder 2022/01
31.
原著
Evaluation of 11C-choline positron emission tomography/computed tomography for determining treatment response in castration-resistant prostate cancer patients. 2022/07
32.
原著
Incidence and Risk Factors of Chest Wall Metastasis at Biopsy Sites in Patients with Malignant Pleural Mesothelioma. 2022/09
33.
症例報告
Detection of Abdominal Lymph Node Metastasis from Pancreatic Neuroendocrine Tumor by Somatostatin Receptor Scintigraphy: Comparison with Somatostatin Receptor Type 2 Immunostaining 2023/01
34.
原著
Novel nomogram developed for determining suitability of metastatic castration-resistant prostate cancer patients to receive maximum benefit from radium-223 dichloride treatment-Japanese Ra-223 Therapy in Prostate Cancer using Bone Scan Index (J-RAP-BSI) Trial. 2023/04
35.
原著
Assessing Therapeutic Response to Radium-223 with an Automated Bone Scan Index among Metastatic Castration-Resistant Prostate Cancer Patients: Data from Patients in the J-RAP-BSI Trial. 2023/05